Results 141 to 150 of about 2,631,955 (205)

Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working Group. [PDF]

J Mol Diagn
Baden J, Sausen M, Anfora AT, D'Auria KM, Dickey J, Godsey JH, Guan L, Lococo JS, Mansfield E, Meier KL, Merriam D, Pawloski T, Shukla S, Stetson D, Stewart MD, Wenz P, Leiman LC.   +16 more
europepmc   +1 more source

The application of compressed sensing on tumor mutation burden calculation from overlapped pooling sequencing data. [PDF]

BMC Bioinformatics
Cui Y, Qiao Y, An R, Pan X, Tu J.
europepmc   +1 more source

Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers. [PDF]

BMC Med Inform Decis Mak
Hu B, Yin G, Zhu J, Bai Y, Sun X.
europepmc   +1 more source

Microsatellite instability (MSI) and the tumor mutation burden (TMB) as biomarkers of response to immune checkpoint inhibitors in prostate cancer. [PDF]

Transl Cancer Res
Voutsadakis IA.
europepmc   +1 more source

Calcium ion-binding genes can predict tumor mutation burden and immune checkpoint blockade response in a pan-cancer model. [PDF]

Discov Oncol
Lin WY, Huang CJ, Wang YC.
europepmc   +1 more source

Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features. [PDF]

PLoS One
Rong F, Cheng B, Guo L, Zeng S, Xu X, Meng Z.   +5 more
europepmc   +1 more source

Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy. [PDF]

Front Immunol
Liao W, Zhou X, Lin H, Feng Z, Chen X, Chen Y, Chen M, Lin M, Yao G, Chen J, Feng H, Wang Y, Tan Z, Tan Y, Lu J, Li P, Wei J, Luo L, Fu L.   +18 more
europepmc   +1 more source

Elevated Tumor Mutation Burden in Cancer Patients with Underlying HIV Infection: Data from the Oncology Research Information Exchange Network (ORIEN). [PDF]

Cancer Epidemiol Biomarkers Prev
Coghill AE, Van Bibber N, Baiocchi RA, Arnold SM, Riedlinger G, Schneider BP, Zhang Y, Suneja G, Gomez Fontela M, Abate-Daga D, Teer JK.   +10 more
europepmc   +1 more source

Synchronous Gastrointestinal Adenocarcinomas with Microsatellite Instability-High, High Tumor Mutation Burden, and a Germline <i>RAD50</i> Frameshift Variant in the Absence of Detectable Pathogenic Germline Mismatch Repair Gene Variants: A Case Report. [PDF]

Case Rep Oncol
Ohtsuka K, Kojima Y, Aso N, Matsushima S, Chisada S, Abe N, Watanabe T, Ohnishi H.   +7 more
europepmc   +1 more source

Clinicopathological characteristics and the relationship of PD-L1 status, tumor mutation burden, and microsatellite instability in patients with esophageal carcinoma. [PDF]

BMC Cancer
Li S, Yu Y, Xu Y, Zhou Y, Huang J, Jia J.   +5 more
europepmc   +1 more source